Latest stories on CTXR
Citius Pharmaceuticals to Participate in September 2026 Investor Conferences
PR Newswire55 · neutralgeneral
Citius Pharmaceuticals Receives Nasdaq Extension to Regain Compliance
TipRanks56 · neutralgeneral
Citius Pharmaceuticals, Inc. (CTXR) files 8-K
SEC 8-K34 · bearishgeneral
Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M
Seeking Alpha34 · bearishearnings
Citius Pharmaceuticals, Inc. (CTXR) files 8-K
SEC 8-K50 · neutralgeneral
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
StockTitan55 · neutralearnings
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
PR Newswire50 · neutralearnings
Citius Pharmaceuticals, Inc. (CTXR) files 8-K
SEC 8-K50 · neutralgeneral
CTXR Expands LYMPHIR Commercial Team and AI Integration, Positioning for Nationwide Growth in 2026
July 21, 2026
MarketChameleon67 · bullishproduct/pr
Citius Highlights LYMPHIR Combo Data in Gynecologic Cancers
TipRanks56 · neutralproduct/pr
Citius Pharmaceuticals GAAP EPS of -$0.95, revenue of $1.7M
Seeking Alpha28 · bearishearnings
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
PR Newswire56 · neutralearnings
Citius raises $36.5m for Lymphir commercialisation
Yahoo Top24 · bearishgeneral